{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:57:10Z","timestamp":1785578230526,"version":"3.56.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11503-8","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:42:15Z","timestamp":1772642535000},"page":"5053-5066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Current advances in 7-hydroxycoumarin derivatives as potential therapeutic agents for Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9212-6628","authenticated-orcid":false,"given":"Hiyashree","family":"Sharmah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5883-1830","authenticated-orcid":false,"given":"Lokman Ali","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2081-1794","authenticated-orcid":false,"given":"Durgaprasad","family":"Kemisetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8381-9509","authenticated-orcid":false,"given":"Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9281-7469","authenticated-orcid":false,"given":"Kumara Swamy","family":"Samanthula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8142-044X","authenticated-orcid":false,"given":"Uttam Prasad","family":"Panigrahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0099-5231","authenticated-orcid":false,"given":"Niladry Sekhar","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"11503_CR1","doi-asserted-by":"publisher","first-page":"100256","DOI":"10.1016\/j.dscb.2025.100256","volume":"19","author":"LA Ahmed","year":"2025","unstructured":"Ahmed LA, Sharmah H (2025) A Concise Review of Synthetic Xanthone Derivatives for Alzheimer\u2019s Disease. Brain Disorders 19:100256. https:\/\/doi.org\/10.1016\/j.dscb.2025.100256","journal-title":"Brain Disorders"},{"key":"11503_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","volume":"43","author":"AL Sosa-Ortiz","year":"2012","unstructured":"Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ (2012) Epidemiology of dementias and Alzheimer\u2019s disease. Arch Med Res 43:600\u2013608. https:\/\/doi.org\/10.1016\/j.arcmed.2012.11.003","journal-title":"Arch Med Res"},{"key":"11503_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-804766-8.00009-1","volume":"167","author":"OL Lopez","year":"2019","unstructured":"Lopez OL, Kuller LH (2019) Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer\u2019s disease and other dementias. Handb Clin Neurol 167:139\u2013148. https:\/\/doi.org\/10.1016\/B978-0-12-804766-8.00009-1","journal-title":"Handb Clin Neurol"},{"key":"11503_CR4","doi-asserted-by":"crossref","unstructured":"Chaudhary RK, Mateti UV, Khanal P et al (2024) Alzheimer\u2019s Disease: Epidemiology, Neuropathology, and Neurochemistry. Computational and Experimental Studies in Alzheimer\u2019s Disease. CRC, pp 1\u201314","DOI":"10.1201\/9781003412069-1"},{"key":"11503_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12939-025-02530-2","volume":"24","author":"C Xu","year":"2025","unstructured":"Xu C, Jiang C, Liu X et al (2025) Epidemiological and sociodemographic transitions in the global burden and risk factors for Alzheimer\u2019s disease and other dementias: a secondary analysis of GBD 2021. Int J Equity Health 24:149. https:\/\/doi.org\/10.1186\/s12939-025-02530-2","journal-title":"Int J Equity Health"},{"key":"11503_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","volume":"9","author":"L Wang","year":"2020","unstructured":"Wang L, Yin Y-L, Liu X-Z et al (2020) Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Transl Neurodegener 9:10. https:\/\/doi.org\/10.1186\/s40035-020-00189-z","journal-title":"Transl Neurodegener"},{"key":"11503_CR7","doi-asserted-by":"crossref","unstructured":"Kormas P, Moutzouri A (2023) Current psychological approaches in neurodegenerative diseases. Handbook of computational neurodegeneration. Springer 261\u2013289","DOI":"10.1007\/978-3-319-75922-7_10"},{"key":"11503_CR8","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"Z-R Chen","year":"2022","unstructured":"Chen Z-R, Huang J-B, Yang S-L et al (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules 27:1816. https:\/\/doi.org\/10.3390\/molecules27061816","journal-title":"Molecules"},{"key":"11503_CR9","doi-asserted-by":"publisher","unstructured":"Arora P, Swati, Rani S et al (2025) Innovative approaches in acetylcholinesterase inhibition: a pathway to effective Alzheimer\u2019s disease treatment. Mol Divers 1\u201330. https:\/\/doi.org\/10.1007\/s11030-025-11170-1","DOI":"10.1007\/s11030-025-11170-1"},{"key":"11503_CR10","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1038\/s41598-018-22747-2","volume":"8","author":"A Kumar","year":"2018","unstructured":"Kumar A, Pintus F, Di Petrillo A et al (2018) Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease. Sci Rep 8:4424. https:\/\/doi.org\/10.1038\/s41598-018-22747-2","journal-title":"Sci Rep"},{"key":"11503_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1021\/acs.accounts.3c00617","volume":"57","author":"FJ Luque","year":"2014","unstructured":"Luque FJ, Mu\u00f1oz-Torrero D (2014) Acetylcholinesterase: a versatile template to coin potent modulators of multiple therapeutic targets. Acc Chem Res 57:450\u2013467. https:\/\/doi.org\/10.1021\/acs.accounts.3c00617","journal-title":"Acc Chem Res"},{"key":"11503_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg005","author":"Y Bourne","year":"2003","unstructured":"Bourne Y, Taylor P, Radi\u0107 Z et al (2003) Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. EMBO J. https:\/\/doi.org\/10.1093\/emboj\/cdg005","journal-title":"EMBO J"},{"key":"11503_CR13","doi-asserted-by":"publisher","first-page":"104217","DOI":"10.1016\/j.drudis.2024.104217","volume":"29","author":"W Bagrowska","year":"2024","unstructured":"Bagrowska W, Karasewicz A, G\u00f3ra A (2024) Comprehensive analysis of acetylcholinesterase inhibitor and reactivator complexes: implications for drug design and antidote development. Drug Discov Today 29:104217. https:\/\/doi.org\/10.1016\/j.drudis.2024.104217","journal-title":"Drug Discov Today"},{"key":"11503_CR14","doi-asserted-by":"publisher","first-page":"105376","DOI":"10.1016\/j.ejps.2020.105376","volume":"151","author":"AM Bond\u017ei\u0107","year":"2020","unstructured":"Bond\u017ei\u0107 AM, Lazarevi\u0107-Pa\u0161ti TD, Leskovac AR et al (2020) A new acetylcholinesterase allosteric site responsible for binding voluminous negatively charged molecules\u2013the role in the mechanism of AChE inhibition. Eur J Pharm Sci 151:105376. https:\/\/doi.org\/10.1016\/j.ejps.2020.105376","journal-title":"Eur J Pharm Sci"},{"key":"11503_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2000.2.2\/lschneider","volume":"2","author":"S Schneider","year":"2000","unstructured":"Schneider S L (2000) A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer\u2019s disease. Dialogues Clin Neurosci 2:111\u2013128. https:\/\/doi.org\/10.31887\/DCNS.2000.2.2\/lschneider","journal-title":"Dialogues Clin Neurosci"},{"key":"11503_CR16","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jsps.2022.10.004","volume":"30","author":"HA Alhazmi","year":"2022","unstructured":"Alhazmi HA, Albratty M (2022) An update on the novel and approved drugs for Alzheimer disease. Saudi Pharm J 30:1755\u20131764. https:\/\/doi.org\/10.1016\/j.jsps.2022.10.004","journal-title":"Saudi Pharm J"},{"key":"11503_CR17","doi-asserted-by":"publisher","unstructured":"Patil VM, Masand N, Gautam V et al (2023) Multi-Target-Directed Ligand Approach in Anti-Alzheimer\u2019s Drug Discovery. Deciphering Drug Targets for Alzheimer\u2019s Disease, Springer 285\u2013319. https:\/\/doi.org\/10.1007\/978-981-99-2657-2_13","DOI":"10.1007\/978-981-99-2657-2_13"},{"key":"11503_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2174\/1385272823666191021124443","volume":"18","author":"VS Gontijo","year":"2020","unstructured":"Gontijo VS, Viegas FPD, Ortiz CJC et al (2020) Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases. Curr Neuropharmacol 18:348\u2013407. https:\/\/doi.org\/10.2174\/1385272823666191021124443","journal-title":"Curr Neuropharmacol"},{"key":"11503_CR19","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.2174\/1381612043383421","volume":"10","author":"MC Carreiras","year":"2004","unstructured":"Carreiras MC, Marco JL (2004) Recent approaches to novel anti-Alzheimer therapy. Curr Pharm Des 10:3167\u20133175. https:\/\/doi.org\/10.2174\/1381612043383421","journal-title":"Curr Pharm Des"},{"key":"11503_CR20","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.2174\/092986711797535245","volume":"18","author":"M Bajda","year":"2011","unstructured":"Bajda M, Guzior N, Ignasik M et al (2011) Multi-target-directed ligands in Alzheimer\u2019s disease treatment. Curr Med Chem 18:4949\u20134975. https:\/\/doi.org\/10.2174\/092986711797535245","journal-title":"Curr Med Chem"},{"key":"11503_CR21","doi-asserted-by":"publisher","unstructured":"Ortiz CJC, de Freitas Silva M, Gontijo VS et al (2018) Design of multi-target directed ligands as a modern approach for the development of innovative drug candidates for Alzheimer\u2019s disease. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. Springer, pp 255\u2013351. https:\/\/doi.org\/10.1007\/7653_2018_2","DOI":"10.1007\/7653_2018_2"},{"key":"11503_CR22","doi-asserted-by":"publisher","first-page":"e70131","DOI":"10.1002\/prp2.70131","volume":"13","author":"MS Hossain","year":"2025","unstructured":"Hossain MS, Hussain MH (2025) Multi-Target Drug Design in Alzheimer\u2019s Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations. Pharmacol Res Perspect 13:e70131. https:\/\/doi.org\/10.1002\/prp2.70131","journal-title":"Pharmacol Res Perspect"},{"key":"11503_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/ph14010033","volume":"14","author":"M Campora","year":"2021","unstructured":"Campora M, Francesconi V, Schenone S et al (2021) Journey on naphthoquinone and anthraquinone derivatives: new insights in Alzheimer\u2019s disease. Pharmaceuticals 14:33. https:\/\/doi.org\/10.3390\/ph14010033","journal-title":"Pharmaceuticals"},{"key":"11503_CR24","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.1021\/acs.jmedchem.1c00167","volume":"64","author":"Q Li","year":"2021","unstructured":"Li Q, Chen Y, Xing S et al (2021) Highly potent and selective butyrylcholinesterase inhibitors for cognitive improvement and neuroprotection. J Med Chem 64:6856\u20136876. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00167","journal-title":"J Med Chem"},{"key":"11503_CR25","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2174\/092986708785909067","volume":"15","author":"D Munoz-Torrero","year":"2008","unstructured":"Munoz-Torrero D (2008) Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer\u2019s disease. Curr Med Chem 15:2433\u20132455. https:\/\/doi.org\/10.2174\/092986708785909067","journal-title":"Curr Med Chem"},{"key":"11503_CR26","doi-asserted-by":"publisher","first-page":"102018","DOI":"10.1016\/j.jics.2025.102018","volume":"10","author":"H Sharmah","year":"2015","unstructured":"Sharmah H, Patowary P, Ahmed LA et al (2015) Coumarin-Indole Hybrids: Synthesis, Characterization & Anti-Inflammatory Evaluation. J Indian Chem Soc 10:102018. https:\/\/doi.org\/10.1016\/j.jics.2025.102018","journal-title":"J Indian Chem Soc"},{"key":"11503_CR27","doi-asserted-by":"publisher","first-page":"108523","DOI":"10.1016\/j.compbiolchem.2025.108523","volume":"119","author":"LA Ahmed","year":"2025","unstructured":"Ahmed LA, Deka B, Sharmah H et al (2025) Design and Synthesis of Novel Xanthone-Thiazole Hybrid Derivatives as Potent Anti-Inflammatory Agent. Comput Biol Chem 119:108523. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108523","journal-title":"Comput Biol Chem"},{"key":"11503_CR28","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.1007\/s11696-024-03614-z","volume":"78","author":"LA Ahmed","year":"2024","unstructured":"Ahmed LA, Deka B, Sharmah H et al (2024) Exploring synthetic xanthone derivatives as potential anti-inflammatory agents: a comprehensive review. Chem Papers 78:7313\u20137333. https:\/\/doi.org\/10.1007\/s11696-024-03614-z","journal-title":"Chem Papers"},{"key":"11503_CR29","first-page":"1607","volume":"14","author":"H Sharmah","year":"2024","unstructured":"Sharmah H, Ahmed LA, Tapadar SB et al (2024) Unveiling the Latest Biological Insights of Indole and its Derivatives: A Compact Review. J Chem Health Risks 14:1607\u20131623","journal-title":"J Chem Health Risks"},{"key":"11503_CR30","doi-asserted-by":"publisher","first-page":"127477","DOI":"10.1016\/j.bmcl.2020.127477","volume":"30","author":"A Singh","year":"2020","unstructured":"Singh A, Sharma S, Arora S et al (2020) New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation. Bioorg Med Chem Lett 30:127477. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127477","journal-title":"Bioorg Med Chem Lett"},{"key":"11503_CR31","doi-asserted-by":"publisher","unstructured":"Das PP, Sharmah H, Ahmed LA et al (2025) Importance of Quinones in Drug Discovery. Quinones: A Privileged Moiety for Drug Discovery. Bentham Science, pp 1\u201317. https:\/\/doi.org\/10.2174\/97988988102761250101","DOI":"10.2174\/97988988102761250101"},{"key":"11503_CR32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/molecules30040891","volume":"30","author":"M Rullo","year":"2025","unstructured":"Rullo M, La Spada G, Stefanachi A et al (2025) Playing Around the Coumarin Core in the Discovery of Multimodal Compounds Directed at Alzheimer\u2019s-Related Targets: A Recent Literature Overview. Molecules 30:891. https:\/\/doi.org\/10.3390\/molecules30040891","journal-title":"Molecules"},{"key":"11503_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cbdd.12629","volume":"87","author":"E Jameel","year":"2016","unstructured":"Jameel E, Umar T, Kumar J et al (2016) Coumarin: a privileged scaffold for the design and development of antineurodegenerative agents. Chem Biol Drug Des 87:21\u201338. https:\/\/doi.org\/10.1111\/cbdd.12629","journal-title":"Chem Biol Drug Des"},{"key":"11503_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/s-0029-1240707","volume":"76","author":"MT Hsieh","year":"2010","unstructured":"Hsieh MT, Peng WH, Wu CR et al (2010) Review on experimental research of herbal medicines with anti-amnesic activity. Planta Med 76:203\u2013217. https:\/\/doi.org\/10.1055\/s-0029-1240707","journal-title":"Planta Med"},{"key":"11503_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.69613\/23spvk43","volume":"2","author":"S Gadamsetti","year":"2024","unstructured":"Gadamsetti S, Kamala G, Degala RP (2024) A Review of Synthesis and Therapeutic Applications of Coumarin Derivatives. J Pharma Insight Res 2:171\u2013183. https:\/\/doi.org\/10.69613\/23spvk43","journal-title":"J Pharma Insight Res"},{"key":"11503_CR36","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/ph16121732","volume":"16","author":"A Kornicka","year":"2023","unstructured":"Kornicka A, Balewski \u0141, Lahutta M et al (2023) Umbelliferone and its synthetic derivatives as suitable molecules for the development of agents with biological activities: a review of their pharmacological and therapeutic potential. Pharmaceuticals 16:1732. https:\/\/doi.org\/10.3390\/ph16121732","journal-title":"Pharmaceuticals"},{"key":"11503_CR37","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2174\/1570159X19666201218103434","volume":"19","author":"M Przyby\u0142owska","year":"2021","unstructured":"Przyby\u0142owska M, Dzierzbicka K, Kowalski S et al (2021) Therapeutic potential of multifunctional derivatives of cholinesterase inhibitors. Curr Neuropharmacol 19:1323\u20131344. https:\/\/doi.org\/10.2174\/1570159X19666201218103434","journal-title":"Curr Neuropharmacol"},{"key":"11503_CR38","doi-asserted-by":"publisher","first-page":"106137","DOI":"10.1016\/j.bioorg.2022.106137","volume":"129","author":"MY Ali","year":"2022","unstructured":"Ali MY, Zaib S, Jannat S et al (2022) Discovery of potent and selective dual cholinesterases and \u03b2-secretase inhibitors in pomegranate as a treatment for Alzheimer\u2019s disease. Bioorg Chem 129:106137. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106137","journal-title":"Bioorg Chem"},{"key":"11503_CR39","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1038\/s41598-025-88944-y","volume":"15","author":"A Sharma","year":"2025","unstructured":"Sharma A, Narang A, Kumar N et al (2025) CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent. Sci Rep 15:4302. https:\/\/doi.org\/10.1038\/s41598-025-88944-y","journal-title":"Sci Rep"},{"key":"11503_CR40","doi-asserted-by":"publisher","first-page":"105424","DOI":"10.1016\/j.ejps.2020.105424","volume":"152","author":"SS Garg","year":"2020","unstructured":"Garg SS, Gupta J, Sharma S et al (2020) An insight into the therapeutic applications of coumarin compounds and their mechanisms of action. Eur J Pharm Sci 152:105424. https:\/\/doi.org\/10.1016\/j.ejps.2020.105424","journal-title":"Eur J Pharm Sci"},{"key":"11503_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s41061-024-00462-z","volume":"382","author":"D Gupta","year":"2024","unstructured":"Gupta D, Guliani E, Bajaj K (2024) Coumarin\u2014synthetic methodologies, pharmacology, and application as natural fluorophore. Top Curr Chem 382:16. https:\/\/doi.org\/10.1007\/s41061-024-00462-z","journal-title":"Top Curr Chem"},{"key":"11503_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.molliq.2015.01.045","volume":"204","author":"J Chen","year":"2015","unstructured":"Chen J, Nan G, Yang R et al (2015) Solubility of three types of benzamide derivatives in toluene, ethyl acetate, acetone, chloroform, methanol, and water at temperatures ranging from 288.15 to 328.15 K at atmospheric pressure. J Mol Liq 204:137\u2013146. https:\/\/doi.org\/10.1016\/j.molliq.2015.01.045","journal-title":"J Mol Liq"},{"key":"11503_CR43","doi-asserted-by":"publisher","first-page":"10403","DOI":"10.1021\/acs.chemrev.9b00145","volume":"119","author":"D Cao","year":"2019","unstructured":"Cao D, Liu Z, Verwilst P et al (2019) Coumarin-based small-molecule fluorescent chemosensors. Chem Rev 119:10403\u201310519. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00145","journal-title":"Chem Rev"},{"key":"11503_CR44","doi-asserted-by":"publisher","DOI":"10.51470\/bca.2024.24.3821","author":"T Bordoloi","year":"2024","unstructured":"Bordoloi T, Wasim I, Sharma H et al (2024) Development of rp-hplc method for estimation of indomethacin in sustained-release capsule samples. Biochem Cell Arch. https:\/\/doi.org\/10.51470\/bca.2024.24.3821","journal-title":"Biochem Cell Arch"},{"key":"11503_CR45","doi-asserted-by":"publisher","first-page":"38709","DOI":"10.1039\/D0RA07999E","volume":"10","author":"T Kusumoto","year":"2020","unstructured":"Kusumoto T, Kitamura H, Hojo S et al (2020) Significant changes in yields of 7-hydroxy-coumarin-3-carboxylic acid produced under FLASH radiotherapy conditions. RSC Adv 10:38709\u201338714. https:\/\/doi.org\/10.1039\/D0RA07999E","journal-title":"RSC Adv"},{"key":"11503_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10600-013-0628-7","volume":"49","author":"H Mostafavi","year":"2013","unstructured":"Mostafavi H, Najjar R, Maskani E (2013) Synthesis and characterization of novel 7-hydroxycoumarin derivatives. Chem Nat Compd 49:423\u2013425. https:\/\/doi.org\/10.1007\/s10600-013-0628-7","journal-title":"Chem Nat Compd"},{"key":"11503_CR47","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1016\/j.ejmech.2011.05.052","volume":"46","author":"JM Timonen","year":"2011","unstructured":"Timonen JM, Nieminen RM, Sareila O et al (2011) Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives. Eur J Med Chem 46:3845\u20133850. https:\/\/doi.org\/10.1016\/j.ejmech.2011.05.052","journal-title":"Eur J Med Chem"},{"key":"11503_CR48","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s11164-013-1258-1","volume":"41","author":"MM Darla","year":"2015","unstructured":"Darla MM, Krishna BS, Umamaheswara Rao K et al (2015) Synthesis and bio-evaluation of novel 7-hydroxy coumarin derivatives via Knoevenagel reaction. RCI 41:1115\u20131133. https:\/\/doi.org\/10.1007\/s11164-013-1258-1","journal-title":"RCI"},{"key":"11503_CR49","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/10826079308020951","volume":"16","author":"S Sharifi","year":"1993","unstructured":"Sharifi S, Michaelis HC, Lotterer E et al (1993) Determination of Coumarin, 7-Hydroxy-Coumarin, 7-Hydroxycoumarin-Glucuronide, and 3-Hydroxycoumarin by High-Performance Liquid Chromatography. J Liq Chromatogr Relat Technol 16:1263\u20131278. https:\/\/doi.org\/10.1080\/10826079308020951","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"11503_CR50","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00044-010-9347-9","volume":"20","author":"NN Farshori","year":"2011","unstructured":"Farshori NN, Banday MR, Ahmad A et al (2011) 7-Hydroxy-coumarin derivatives: synthesis, characterization and preliminary antimicrobial activities. Med Chem Res 20:535\u2013541. https:\/\/doi.org\/10.1007\/s00044-010-9347-9","journal-title":"Med Chem Res"},{"key":"11503_CR51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/1570179420666230427110019","volume":"21","author":"V Yadav","year":"2024","unstructured":"Yadav V, Thakur A, Bharti R et al (2024) Recent Advancement in Multicomponent Synthesis of Fused Coumarin Derivatives. Curr Org Synth 21:303\u2013330. https:\/\/doi.org\/10.2174\/1570179420666230427110019","journal-title":"Curr Org Synth"},{"key":"11503_CR52","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.3390\/molecules27217256","volume":"27","author":"MD Douka","year":"2022","unstructured":"Douka MD, Litinas KE (2022) An overview on the synthesis of fused pyridocoumarins with biological interest. Molecules 27:7256. https:\/\/doi.org\/10.3390\/molecules27217256","journal-title":"Molecules"},{"key":"11503_CR53","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.2174\/1385272823666191121150047","volume":"23","author":"CS Francisco","year":"2019","unstructured":"Francisco CS, Francisco CS, Constantino AF et al (2019) Synthetic methods applied in the preparation of coumarin-based compounds. Curr Org Synth 23:2722\u20132750. https:\/\/doi.org\/10.2174\/1385272823666191121150047","journal-title":"Curr Org Synth"},{"key":"11503_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.56808\/3027-7922.1992","volume":"38","author":"T Hiranyaekaphap","year":"2013","unstructured":"Hiranyaekaphap T, Srimongkolpithak N, Wongchang T et al (2013) Discovery of novel cholinesterase inhibitor (rknu026) with \u03b2-Amyloid aggregation inhibitory activity. Thai J Pharm Sci 38:4\u20137. https:\/\/doi.org\/10.56808\/3027-7922.1992","journal-title":"Thai J Pharm Sci"},{"key":"11503_CR55","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ejmech.2014.05.056","volume":"82","author":"M Alipour","year":"2014","unstructured":"Alipour M, Khoobi M, Moradi A et al (2014) Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives. Eur J Med Chem 82:536\u2013544. https:\/\/doi.org\/10.1016\/j.ejmech.2014.05.056","journal-title":"Eur J Med Chem"},{"key":"11503_CR56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejmech.2015.10.046","volume":"107","author":"JB Shaik","year":"2015","unstructured":"Shaik JB, Palaka BK, Penumala M et al (2015) Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents. Eur J Med Chem 107:219\u2013232. https:\/\/doi.org\/10.1016\/j.ejmech.2015.10.046","journal-title":"Eur J Med Chem"},{"key":"11503_CR57","first-page":"2742","volume":"1","author":"JL Dom\u00ednguez","year":"2016","unstructured":"Dom\u00ednguez JL, Fern\u00e1ndez-nieto F, Brea JM et al (2016) 8-Aminomethyl-7-hydroxy-4-methylcoumarins as Multitarget Leads for Alzheimer. \u2019 s Disease 1:2742\u20132749","journal-title":"\u2019 s Disease"},{"key":"11503_CR58","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/cmdc.201500392","volume":"11","author":"S Montanari","year":"2016","unstructured":"Montanari S, Bartolini M, Neviani P et al (2016) Multitarget Strategy to Address Alzheimer\u2019s Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives. ChemMedChem 11:1296\u20131308. https:\/\/doi.org\/10.1002\/cmdc.201500392","journal-title":"ChemMedChem"},{"key":"11503_CR59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jinorgbio.2016.05.001","volume":"161","author":"S Hamulakova","year":"2016","unstructured":"Hamulakova S, Poprac P, Jomova K et al (2016) Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer\u2019s disease using multifunctional tacrine-coumarin hybrid molecules. J Inorg Biochem 161:52\u201362. https:\/\/doi.org\/10.1016\/j.jinorgbio.2016.05.001","journal-title":"J Inorg Biochem"},{"key":"11503_CR60","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cmdc.201700282","volume":"12","author":"L Pisani","year":"2017","unstructured":"Pisani L, Catto M, De Palma A et al (2017) Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties. ChemMedChem 12:1349\u20131358. https:\/\/doi.org\/10.1002\/cmdc.201700282","journal-title":"ChemMedChem"},{"key":"11503_CR61","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ejmech.2018.04.058","volume":"152","author":"L Jalili-Baleh","year":"2018","unstructured":"Jalili-Baleh L, Forootanfar H, K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 TT et al (2018) Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer\u2019s disease based on coumarin and lipoic acid scaffolds. Eur J Med Chem 152:600\u2013614. https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.058","journal-title":"Eur J Med Chem"},{"key":"11503_CR62","doi-asserted-by":"publisher","first-page":"104792","DOI":"10.1016\/j.bioorg.2021.104792","volume":"110","author":"KM Amin","year":"2021","unstructured":"Amin KM, Abdel Rahman DE, Abdelrasheed Allam H et al (2021) Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Bioorg Chem 110:104792. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104792","journal-title":"Bioorg Chem"},{"key":"11503_CR63","doi-asserted-by":"publisher","unstructured":"Narayanan SE, Narayanan H, Mukundan M et al (2021) Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer\u2019s disease. Futur J Pharm Sci 7. https:\/\/doi.org\/10.1186\/s43094-021-00278-4","DOI":"10.1186\/s43094-021-00278-4"},{"key":"11503_CR64","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1080\/14756366.2021.1913137","volume":"36","author":"SC Mzezewa","year":"2021","unstructured":"Mzezewa SC, Omoruyi SI, Zondagh LS et al (2021) Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer\u2019s disease agents. J Enzyme Inhib Med Chem 36:1607\u20131621. https:\/\/doi.org\/10.1080\/14756366.2021.1913137","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11503_CR65","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.ijbiomac.2021.10.204","volume":"193","author":"JB Shaik","year":"2021","unstructured":"Shaik JB, Kandrakonda YR, Kallubai M et al (2021) Deciphering the AChE-binding mechanism with multifunctional tricyclic coumarin anti-Alzheimer\u2019s agents using biophysical and bioinformatics approaches and evaluation of their modulating effect on Amyloidogenic peptide assembly. Int J Biol Macromol 193:1409\u20131420. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.10.204","journal-title":"Int J Biol Macromol"},{"key":"11503_CR66","doi-asserted-by":"publisher","first-page":"101977","DOI":"10.1016\/j.jksus.2022.101977","volume":"34","author":"N George","year":"2022","unstructured":"George N, Sabahi BA, AbuKhader M et al (2022) Design, synthesis and in vitro biological activities of coumarin linked 1,3,4-oxadiazole hybrids as potential multi-target directed anti-Alzheimer agents. J King Saud Univ Sci 34:101977. https:\/\/doi.org\/10.1016\/j.jksus.2022.101977","journal-title":"J King Saud Univ Sci"},{"key":"11503_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cbdv.202200315","volume":"19","author":"I Erdogan Orhan","year":"2022","unstructured":"Erdogan Orhan I, Deniz FSS, Salmas RE et al (2022) Evaluation of Anti-Alzheimer Activity of Synthetic Coumarins by Combination of in Vitro and in Silico Approaches. Chem Biodivers 19:1\u201311. https:\/\/doi.org\/10.1002\/cbdv.202200315","journal-title":"Chem Biodivers"},{"key":"11503_CR68","doi-asserted-by":"publisher","unstructured":"Sharma A, Nuthakki VK, Gairola S et al (2022) A Coumarin\u2013Donepezil Hybrid as a Blood\u2013Brain Barrier Permeable Dual Cholinesterase Inhibitor: Isolation, Synthetic Modifications, and Biological Evaluation of Natural Coumarins. ChemMedChem 17. https:\/\/doi.org\/10.1002\/cmdc.202200300","DOI":"10.1002\/cmdc.202200300"},{"key":"11503_CR69","doi-asserted-by":"publisher","unstructured":"Berrino E, Carradori S, Carta F et al (2023) A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration. Antioxidants 12. https:\/\/doi.org\/10.3390\/antiox12122044","DOI":"10.3390\/antiox12122044"},{"key":"11503_CR70","doi-asserted-by":"publisher","first-page":"18496","DOI":"10.1039\/d3ra02344c","volume":"13","author":"NN Kamel","year":"2023","unstructured":"Kamel NN, Aly HF, Fouad GI et al (2023) Anti-Alzheimer activity of new coumarin-based derivatives targeting acetylcholinesterase inhibition. RSC Adv 13:18496\u201318510. https:\/\/doi.org\/10.1039\/d3ra02344c","journal-title":"RSC Adv"},{"key":"11503_CR71","doi-asserted-by":"publisher","unstructured":"Wang H, Su M, Shi X et al (2023) Design, Synthesis, Calculation and Biological Activity Studies Based on Privileged Coumarin Derivatives as Multifunctional Anti-AD Lead Compound. Chem Biodivers 20. https:\/\/doi.org\/10.1002\/cbdv.202200867","DOI":"10.1002\/cbdv.202200867"},{"key":"11503_CR72","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s11094-024-03245-4","volume":"58","author":"S Bhawana","year":"2024","unstructured":"Bhawana S, Alka T, Anurag (2024) Design, Creation, and Biological Screening of Newer Coumarin-Coupled Heterocyclic Hybrids as Acetylcholinesterase Inhibitors that may be Useful in the Treatment of Alzheimer\u2019s Disease. Pharm Chem J 58:1069\u20131083. https:\/\/doi.org\/10.1007\/s11094-024-03245-4","journal-title":"Pharm Chem J"},{"key":"11503_CR73","doi-asserted-by":"publisher","first-page":"483","DOI":"10.56042\/ijct.v31i3.3786","volume":"31","author":"T Jaber","year":"2024","unstructured":"Jaber T, More UA, Sidat P et al (2024) Design, synthesis and evaluation of novel coumarin-oxa\/thiadiazole hybrids as AChE inhibitors for the treatment of alzheimer\u2019s disease. Indian J Chem Technol 31:483\u2013493. https:\/\/doi.org\/10.56042\/ijct.v31i3.3786","journal-title":"Indian J Chem Technol"},{"key":"11503_CR74","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1039\/d4md00782d","volume":"16","author":"A Singh","year":"2024","unstructured":"Singh A, Sharma A, Singh K et al (2024) Development of coumarin-inspired bifunctional hybrids as a new class of anti-Alzheimer\u2019s agents with potent in vivo efficacy. RSC Med Chem 16:1986\u20132003. https:\/\/doi.org\/10.1039\/d4md00782d","journal-title":"RSC Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11503-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:39:07Z","timestamp":1783161547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11503-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":74,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11503"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11503-8","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}